Pharmaceutical Business Review
Anonymous User | Login

Dyax Unveils New Developments Related To Phage Display Technology

Published: 13-Oct-2009

Sanofi-aventis to acquire Dyax’s ophthalmic partner, Fovea Pharmaceuticals

Dyax has unveiled new developments involving drug candidates identified using the company’s phage display technology as a result of two deals recently announced by sanofi-aventis.

Sanofi-aventis is planning to acquire Fovea Pharmaceuticals, Dyax’s partner for DX-88 in ophthalmic indications in the European Union (EU). Under the terms of the Dyax-Fovea partnership agreement, Fovea has exclusive rights to the intravitreal formulation of DX-88 in ophthalmic indications in the EU. Fovea will fully fund development for the retinal vein occlusion (RVO) induced macular edema program for approval in worldwide markets. Dyax has retained rights for ophthalmic indications for all territories outside the EU.

Separately, sanofi-aventis has entered into collaboration and licensing agreement with Merrimack Pharmaceuticals, a licensee under Dyax’s Licensing and Funded Research Program (LFRP), for rights to MM-121. It was identified using Dyax's antibody phage display library and is currently in phase 1 development in oncology. Dyax is eligible to receive milestones associated with the development of MM-121, including royalties upon commercialization.

Reportedly, Dyax has a relationship with sanofi-aventis that began in February 2008, when sanofi-aventis licensed rights to its human monoclonal antibody DX-2240 and to the phage display technology in a deal valued up to $500m for Dyax. Dyax received $25m in upfront payments in 2008.

Gustav Christensen, president and CEO of Dyax, said: “We are pleased that DX-88 in retinal disease has been recognized as a key asset in the proposed acquisition of Fovea. Furthermore, these deals, which involve two drug candidates generated from our proprietary phage display libraries, further validate our technology as an important drug discovery platform.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

World Courier

Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...

WebWise Learning

Turning Information into Working Knowledge ...

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Valsynthese

Hazardous Chemistry in Safe Hands ...

USB

Products from Affymetrix ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

Sanofi-Aventis

Sanofi-Aventis (Sanofi-aventis) is a global pharmaceutical company engaged in the resea ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Dyax Corp.

Dyax Corp. (Dyax) is a clinical stage biotechnology company dealing with the discovery, ...

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manuf ...

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the desig ...

Suppliers Product News

World Courier CTSCS Depots Provide Dedicated Storage for GMO Products

In response to growing client demand and based on recently-established international biosafety regulations, World Courier has begun rolling out dedicated storage areas for GMO-derived pharmaceutical products throughout its global investigational drug storage network.

World Courier Triples Clinical Trial Storage Capacity Worldwide with Two New Facilities and Client-Driven Expansion

World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia.

World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management

With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address